UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
American journal of respiratory and critical care medicine, ISSN 1073-449X, 01/2014, Volume 189, Issue 2, pp. 214 - 222
Extracellular matrix | Inflammation | Interstitial lung disease | Idiopathic pulmonary fibrosis | Alveolar epithelial cells | Idiopathic Pulmonary Fibrosis - therapy | Genetic Predisposition to Disease | Pulmonary Alveoli - pathology | Humans | Biomedical Research - trends | Inflammation - immunology | Respiratory Mucosa - pathology | Animals | Idiopathic Pulmonary Fibrosis - diagnosis | Idiopathic Pulmonary Fibrosis - physiopathology | Mice | Extracellular Matrix - pathology | Disease Models, Animal | Index Medicus | Abridged Index Medicus | alveolar epithelial cells | idiopathic pulmonary fibrosis | NHLBI Workshop | interstitial lung disease | inflammation | extracellular matrix
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 05/2012, Volume 185, Issue 10, pp. 1044 - 1048
Endpoints | Clinical trials | Surrogate endpoints | Survival | Idiopathic pulmonary fibrosis | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Intensive care medicine | Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Pneumology | Severity of Illness Index | Humans | Endpoint Determination - methods | Respiratory System Agents - therapeutic use | Treatment Outcome | Hospitalization | Clinical Trials, Phase III as Topic - methods | Idiopathic Pulmonary Fibrosis - surgery | Lung Transplantation | Idiopathic Pulmonary Fibrosis - mortality | Survival Analysis | Biomarkers | Idiopathic Pulmonary Fibrosis - drug therapy | Index Medicus | Abridged Index Medicus | endpoints | clinical trials | idiopathic pulmonary fibrosis | Pulmonary | surrogate endpoints | survival
Journal Article
Respiratory research, ISSN 1465-9921, 07/2013, Volume 14, Issue 1, pp. 73 - 73
Endpoints | Clinical trials | Pulmonary fibrosis | Acute exacerbation | Life Sciences & Biomedicine | Respiratory System | Science & Technology | Outcome Assessment (Health Care) - methods | Sulfones - therapeutic use | Acute Disease | Reproducibility of Results | Humans | Middle Aged | Male | Treatment Outcome | Piperazines - therapeutic use | Disease Progression | Sildenafil Citrate | Idiopathic Pulmonary Fibrosis - diagnosis | Sensitivity and Specificity | Adult | Female | Aged | Phosphodiesterase 5 Inhibitors - therapeutic use | Purines - therapeutic use | Clinical Trials as Topic - methods | Idiopathic Pulmonary Fibrosis - drug therapy | Medicine, Experimental | Medical research | Survival analysis | Medical treatment | Mortality | Questionnaires | Tomography | Carbon monoxide | Index Medicus | Research
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 07/2012, Volume 186, Issue 1, pp. 88 - 95
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Intensive care medicine | Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Pneumology | Double-Blind Method | Humans | Middle Aged | Hospitalization - statistics & numerical data | Anticoagulants - therapeutic use | Male | Warfarin - therapeutic use | International Normalized Ratio | Idiopathic Pulmonary Fibrosis - mortality | Treatment Failure | Aged, 80 and over | Adult | Female | Aged | Idiopathic Pulmonary Fibrosis - physiopathology | Idiopathic Pulmonary Fibrosis - drug therapy | Index Medicus | Abridged Index Medicus | clinical trial | idiopathic pulmonary fibrosis | anticoagulation | warfarin
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2010, Volume 363, Issue 7, pp. 620 - 628
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Sulfones - therapeutic use | Vasodilator Agents - therapeutic use | Humans | Middle Aged | Sulfones - adverse effects | Male | Dyspnea - etiology | Sildenafil Citrate | Exercise Test | Female | Purines - adverse effects | Purines - therapeutic use | Double-Blind Method | Administration, Oral | Treatment Outcome | Piperazines - therapeutic use | Piperazines - adverse effects | Oxygen - blood | Pulmonary Diffusing Capacity | Idiopathic Pulmonary Fibrosis - mortality | Quality of Life | Dyspnea - drug therapy | Aged | Idiopathic Pulmonary Fibrosis - physiopathology | Respiratory Function Tests | Vasodilator Agents - adverse effects | Idiopathic Pulmonary Fibrosis - drug therapy | Pulmonary fibrosis | Patient outcomes | Analysis | Sildenafil | Drug therapy | Health aspects | Quality of life | Lungs | Index Medicus | Abridged Index Medicus
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 04/2017, Volume 195, Issue 7, pp. 921 - 929
Idiopathic pulmonary fibrosis | Prognosis | Multidetector computed tomography | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Prospective Studies | Respiratory Function Tests - statistics & numerical data | Humans | Idiopathic Pulmonary Fibrosis - diagnostic imaging | Tomography, X-Ray Computed - methods | Male | Lung - diagnostic imaging | Lung - physiopathology | Image Processing, Computer-Assisted - methods | Disease Progression | Female | Aged | Idiopathic Pulmonary Fibrosis - physiopathology | Index Medicus | Abridged Index Medicus | idiopathic pulmonary fibrosis | Original | prognosis | multidetector computed tomography
Journal Article
The New England journal of medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 24, pp. 2314 - 2324
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Isosorbide Dinitrate - analogs & derivatives | Double-Blind Method | Vasodilator Agents - therapeutic use | Humans | Middle Aged | Heart Failure - physiopathology | Male | Motor Activity | Heart Failure - drug therapy | Cross-Over Studies | Stroke Volume | Walking | Exercise Tolerance | Peptide Fragments - blood | Quality of Life | Female | Isosorbide Dinitrate - adverse effects | Aged | Isosorbide Dinitrate - therapeutic use | Vasodilator Agents - adverse effects | Accelerometry | Natriuretic Peptide, Brain - blood | Heart failure | Care and treatment | Exercise | Analysis | Isosorbide mononitrate | Dosage and administration | Cardiac output | Health aspects | Quality of life | Accelerometers | Brain natriuretic peptide | Physical fitness | Heart attacks | Nitrates | Cardiology | Patients | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 21, pp. 2032 - 2042
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Heart-Assist Devices - statistics & numerical data | Myocardial Infarction - epidemiology | Simendan | Humans | Middle Aged | Male | Cardiotonic Agents - therapeutic use | Cardiac Surgical Procedures | Hydrazones - adverse effects | Cardiotonic Agents - adverse effects | Hydrazones - therapeutic use | Treatment Failure | Female | Cardiac Output, Low - drug therapy | Postoperative Complications - drug therapy | Renal Replacement Therapy - statistics & numerical data | Pyridazines - adverse effects | Pyridazines - therapeutic use | Double-Blind Method | Mortality | Stroke Volume - drug effects | Perioperative Period | Ventricular Dysfunction, Left - drug therapy | Aged | Infusions, Intravenous | Heart failure | Heart | Treatment outcome | Usage | Analysis | Surgery | Dosage and administration | Diagnosis | Cardiovascular agents | Heart surgery | Clinical trials | Drug therapy | Clinical outcomes | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Chest, ISSN 0012-3692, 2013, Volume 143, Issue 6, pp. 1699 - 1708
Pulmonary/Respiratory | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Sulfones - therapeutic use | Vasodilator Agents - therapeutic use | Humans | Idiopathic Pulmonary Fibrosis - diagnostic imaging | Male | Hypertrophy, Right Ventricular - drug therapy | Walking - physiology | Sildenafil Citrate | Hypertrophy, Right Ventricular - physiopathology | Hypertrophy, Right Ventricular - diagnostic imaging | Statistics, Nonparametric | Placebos | Female | Surveys and Questionnaires | Ventricular Dysfunction, Right - physiopathology | Purines - therapeutic use | Echocardiography | Double-Blind Method | Ventricular Dysfunction, Right - drug therapy | Piperazines - therapeutic use | Chi-Square Distribution | Regression Analysis | Quality of Life | Aged | Idiopathic Pulmonary Fibrosis - physiopathology | Respiratory Function Tests | Idiopathic Pulmonary Fibrosis - drug therapy | Ventricular Dysfunction, Right - diagnostic imaging | Care and treatment | Exercise | Demographic aspects | Physiological aspects | Cystic fibrosis | Dosage and administration | Ventricular function | Sildenafil | Research | Index Medicus | Abridged Index Medicus | Original Research
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 03/2013, Volume 309, Issue 12, pp. 1 - 10
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Cardiovascular system | General aspects | Investigative techniques, diagnostic techniques (general aspects) | Biological and medical sciences | Investigative techniques of hemodynamics | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Blood Pressure | Sulfones - therapeutic use | Double-Blind Method | Humans | Middle Aged | Heart Failure - physiopathology | Oxygen Consumption | Male | Treatment Outcome | Piperazines - therapeutic use | Heart Failure - drug therapy | Sildenafil Citrate | Stroke Volume | Walking | Outpatients | Exercise Tolerance | Female | Aged | Phosphodiesterase 5 Inhibitors - therapeutic use | Purines - therapeutic use | Health Status | Heart failure | Clinical trials | Enzymes | Medical research | Index Medicus | Abridged Index Medicus
Journal Article